Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Tavanti, A."'
Autor:
Barbara Rolando, Marilù Fanelli, Ilaria Buondonno, Elisa Tavanti, Alberto Gasco, Konstantin Chegaev, Massimo Serra, Chiara Riganti, Claudia Maria Hattinger, Elena Gazzano, Joanna Kopecka, Roberta Fruttero
Publikováno v:
Cellular and Molecular Life Sciences. 76:609-625
Doxorubicin is one of the most effective drugs for the first-line treatment of high-grade osteosarcoma. Several studies have demonstrated that the major cause for doxorubicin resistance in osteosarcoma is the increased expression of the drug efflux t
Autor:
Vella, Serena1, Tavanti, Elisa1, Hattinger, Claudia Maria1, Fanelli, Marilù1, Versteeg, Rogier2, Koster, Jan3, Picci, Piero1, Serra, Massimo1 massimo.serra@ior.it
Publikováno v:
PLoS ONE. 11/29/2016, Vol. 11 Issue 11, p1-20. 20p.
Autor:
Sara Gagno, Erika Iacoboni, Serena Vella, Rossana Roncato, Piero Picci, Massimo Serra, Giuseppe Toffoli, Stefano Ferrari, Marilù Fanelli, Andrea Roli, Claudia Maria Hattinger, Luciana Giodini, Elisa Tavanti, Paola Biason, Katia Scotlandi
Publikováno v:
Oncotarget. 7:61970-61987
// Claudia M. Hattinger 1 , Paola Biason 2 , Erika Iacoboni 1 , Sara Gagno 3 , Marilu Fanelli 1 , Elisa Tavanti 1 , Serena Vella 1 , Stefano Ferrari 4 , Andrea Roli 5 , Rossana Roncato 3 , Luciana Giodini 3 , Katia Scotlandi 1 , Piero Picci 1 , Giuse
Autor:
Chiara Giacomelli, Simona Daniele, Chiara Romei, Laura Tavanti, Tommaso Neri, Ilaria Piano, Alessandro Celi, Claudia Martini, Maria L. Trincavelli
Publikováno v:
Frontiers in Pharmacology, Vol 9 (2018)
The epithelial-mesenchymal transition (EMT) is a complex process in which cell phenotype switches from the epithelial to mesenchymal one. The deregulations of this process have been related with the occurrence of different diseases such as lung cance
Autor:
Daria Bottai, Brunella Posteraro, Antonella Lupetti, Cosmeri Rizzato, Enrica Mello, Maurizio Sanguinetti, Noemi Poma, Marina Zoppo, Arianna Tavanti
Publikováno v:
The Journal of antimicrobial chemotherapy. 73(7)
Background Candida orthopsilosis is a human fungal pathogen responsible for a wide spectrum of symptomatic infections. Evidence suggests that C. orthopsilosis is mainly susceptible to azoles, the most extensively used antifungals for treatment of the
Autor:
Chiara, Giacomelli, Simona, Daniele, Chiara, Romei, Laura, Tavanti, Tommaso, Neri, Ilaria, Piano, Alessandro, Celi, Claudia, Martini, Maria L, Trincavelli
Publikováno v:
Frontiers in Pharmacology
The epithelial-mesenchymal transition (EMT) is a complex process in which cell phenotype switches from the epithelial to mesenchymal one. The deregulations of this process have been related with the occurrence of different diseases such as lung cance
Autor:
Massimo Serra, Claudia Maria Hattinger, Piero Picci, Elisa Tavanti, Serena Vella, Stefano Ferrari, Marilù Fanelli
Publikováno v:
Expert Opinion on Emerging Drugs. 20:495-514
Osteosarcoma (OS), the most common primary malignant bone tumor, is currently treated with pre- and postoperative chemotherapy in association with the surgical removal of the tumor. Conventional treatments allow to cure about 60 - 65% of patients wit
Autor:
Arianna Tavanti, Simona Paulone, Luciano Polonelli, Claudio Cermelli, Cosmeri Rizzato, Samuele Peppoloni, Stefania Conti, Andrea Ardizzoni, Brunella Posteraro, Eva Pericolini, Bruna Colombari, Antonella Lupetti, Serena Piccinelli, Elisabetta Blasi, Walter Magliani
Publikováno v:
PLoS ONE, Vol 12, Iss 7, p e0181278 (2017)
PLoS ONE
PLoS ONE
Candida albicans is a commensal organism, commonly inhabiting mucosal surfaces of healthy individuals, as a part of the resident microbiota. However, in susceptible hosts, especially hospitalized and/or immunocompromised patients, it may cause a wide
Autor:
Piero Picci, Serena Vella, Elisa Tavanti, Massimo Serra, Claudia Maria Hattinger, Marilù Fanelli
Publikováno v:
Pharmacogenomics. 17(18)
Second-line treatment of high-grade osteosarcoma (HGOS) patients is based on different approaches and chemotherapy protocols, which are not yet standardized. Although several drugs have been used in HGOS second-line protocols, none of them has provid
Autor:
Marilù Fanelli, Claudia Maria Hattinger, Serena Vella, Elisa Tavanti, Piero Picci, Massimo Serra
Publikováno v:
Expert opinion on drug metabolismtoxicology. 13(3)
Antifolates are structural analogs of folates, which have been used as antitumor drugs for more than 60 years. The antifolate drug most commonly used for treating human tumors is methotrexate (MTX), which is utilized widely in first-line treatment pr